Growth Metrics

Pfizer (PFE) Gross Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -12,305.00
Sep 28, 2025 -16,202.00
Jun 29, 2025 -14,770.00
Mar 30, 2025 -11,540.00
Sep 29, 2024 -117,020.00
Jun 30, 2024 -542.00
Mar 31, 2024 -416.00
Dec 31, 2023 -14,976.00
Oct 1, 2023 -54,321.00
Jul 2, 2023 -7,110.00
Apr 2, 2023 -11,485.00
Oct 2, 2022 -518.00
Jul 3, 2022 -1,055.00
Apr 3, 2022 -1,959.00
Oct 3, 2021 -1,767.00
Jul 4, 2021 -1,288.00
Apr 4, 2021 -672.00
Sep 27, 2020 -117.00
Jun 28, 2020 -12.00
Mar 29, 2020 -232.00
Sep 29, 2019 -136.00
Jun 30, 2019 -15.00
Mar 31, 2019 -53.00
Dec 31, 2018 -4,987.00
Sep 30, 2018 -217.00
Jul 1, 2018 -437.00
Apr 1, 2018 -162.00
Dec 31, 2017 -394.00
Oct 1, 2017 -377.00
Jul 2, 2017 -362.00
Apr 2, 2017 -87.00
Dec 31, 2016 -635.00
Oct 2, 2016 -312.00
Jul 3, 2016 -248.00
Apr 3, 2016 46.00
Dec 31, 2015 -415.00
Sep 27, 2015 534.00
Jun 28, 2015 311.00
Mar 29, 2015 843.00
Dec 31, 2014 160.00
Sep 28, 2014 -376.00
Jun 29, 2014 -329.00
Mar 30, 2014 -506.00